GlassScriptPhysician profile
Eunice H Cho
NPI 1053727529
$17,950.18
in general payments reported to CMS, 2019-2025
42 companies · $856 in 2025
The $856 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,485 · 2020: $295 · 2021: $6,103 · 2022: $4,087 · 2023: $1,848 · 2024: $2,277 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,658 · Travel and Lodging: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,658.21 |
| Travel and Lodging | $1,322.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequoia Surgical, INC. | $5,011.71 | 2019-2021 | |
| Biotissue Holdings INC. | $2,110.93 | 2021-2024 | |
| Paragon 28, INC. | $1,710.72 | 2021-2022 | |
| Treace Medical Concepts, INC. | $1,559.95 | 2019-2025 | |
| Stryker Corporation | $1,537.36 | 2019-2023 | Salvation, Citrefix, Prostep |
| Arthrex, INC. | $1,232.43 | 2021-2024 | |
| Evolution Surgical, INC | $1,000.72 | 2024-2025 | |
| Smith+Nephew, INC. | $583.56 | 2019-2025 | Cadence, Renasys, Regranex |
| Bioventus LLC | $404.05 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $340.55 | 2019-2025 | Physio-Stim |
| Integra Lifesciences Corporation | $251.24 | 2019-2021 | |
| Medtronic, INC. | $240.43 | 2022-2023 | Intellis Adaptivestim |
| Cardiovascular Systems INC. | $196.34 | 2022 | |
| Depuy Synthes Sales INC. | $186.47 | 2024-2025 | Motoband, Fibulink, Minibunion |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $153.56 | 2021-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $142.42 | 2020-2025 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $128.07 | 2023 | |
| Next Science LLC | $112.36 | 2022 | |
| Organogenesis INC. | $106.73 | 2020-2024 | Nushield |
| Amgen INC. | $80.63 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $76.89 | 2019-2023 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $66.78 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.99 | 2023-2025 | Jublia |
| Linvatec Corporation | $48.74 | 2025 | Biobrace 23mm |
| Merck Sharp & Dohme LLC | $46.58 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $41.74 | 2024 | Exparel |
| Alfasigma USA, INC. | $41.29 | 2021-2022 | |
| Medela LLC | $28.28 | 2020-2021 | |
| Zimvie INC. | $26.32 | 2022 | |
| Alexion Pharmaceuticals, INC. | $25.65 | 2022 | |
| Tenex Health INC. | $25.55 | 2019 | |
| Grt US Holding, INC. | $25.44 | 2022 | |
| Kuros Biosciences USA, INC | $22.65 | 2025 | Magnetos |
| Osiris Therapeutics INC. | $22.18 | 2019 | |
| Melinta Therapeutics, LLC | $21.42 | 2022 | |
| Acell, INC. | $21.24 | 2020 | |
| Averitas Pharma INC. | $20.78 | 2024 | Qutenza |
| Curonix LLC | $20.02 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kerecis Limited | $17.75 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kowa Pharmaceuticals America, INC. | $15.58 | 2022 | |
| Hartmann USA, INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunice Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.